Search - tctmd.com

Displaying 41 - 60 of 136

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Shelley Wood

September 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

Podcast Heart Sounds

August 2022: Top Takeaways from ESC 2022

August 31, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

Smartphone App Can Detect AF, Influence Care: eBRAVE-AF

Caitlin E. Cox

August 30, 2022

Presentation ESC 2022

DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults

Presenter: Niklas Dyrby Johansen

August 29, 2022

Presentation ESC 2022

Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR)

Presenter: Wilfried Mullens

August 29, 2022

Presentation ESC 2022

Treatment In the Morning or Evening: The TIME Study Results

Presenter: Thomas MacDonald

August 29, 2022

Presentation ESC 2022

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Presenter: Valentin Fuster

August 29, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News ESC 2022

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Shelley Wood

August 29, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation ESC 2022

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Presenter: Sripal Bangalore

August 29, 2022

Presentation ESC 2022

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Presenter: Michelle L. O’Donoghue

August 29, 2022

Advertisement

September 2022 News Roundup

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

TCTMD’s Top 10 Most Popular Stories for August 2022

August 2022: Top Takeaways from ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Smartphone App Can Detect AF, Influence Care: eBRAVE-AF

DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults

Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR)

Treatment In the Morning or Evening: The TIME Study Results

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Less Death, Major Bleeding With Transradial Access: Meta-analysis

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

FFR vs. Angiography-guided PCI in AMI with multivessel disease

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content